Share price development
Eurofins shares are listed on Euronext Paris
IPO on 24 October 1997
ISIN code: FR0014000MR3
Ticker codes: Reuters EUFI.PA, Bloomberg ERF FP
Index membership
Euronext Paris
CAC 40, EURONEXT 100, SBF 120, SBF TOP 80 EW, CAC ALL SHARE, CAC ALL-TRADABLE, CAC HEALTH CARE, CAC LARGE 60.
Euronext Amsterdam
EN EUROPE 500, EN EUROZONE 300, EN DEV EU.
Other
MSCI Europe, STOXX Europe 600, S&P Europe 350
As of 31 December 2025
Industry classification
GICS Sector: Healthcare
GICS Industry Group: Pharmaceuticals, Biotechnology & Life Sciences
GICS Sub-Industry: Life Sciences Tools & Services
Ownership structure
Free float: 61.7%
Martin family: 35.2%
As of 31 December 2025
More information on the ownership structure can be found in Eurofins’ most recent Annual and Half-year Reports.
Analyst coverage
Eurofins Scientific S.E. is covered by the analysts listed below.
Please note that any opinions, estimates or forecasts regarding Eurofins’ performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Eurofins or its management.
Eurofins does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions, or recommendations.
| AlphaValue | Kulwinder Rajpal |
| Bank of America | Virginia Montorsi |
| Barclays | James Rowland Clark |
| BernsteinSG | Delphine Le Louet |
| BNP Paribas | Tom Burlton |
| CIC Market Solutions | Arnaud Cadart |
| Citi | Arthur Truslove |
| Deutsche Bank | Ben Wild |
| Goldman Sachs | Suhasini Varanasi |
| Jefferies | Allen Wells |
| Kepler Cheuvreux | Francois Digard |
| Morgan Stanley | Remi Grenu |
| Morningstar | Max Jousma |
| ODDO BHF | Geoffroy Michalet |
| Redburn | Neil Tyler |